Statistically significant negative correlations were seen between pre-chemotherapy NLR and ER-negative (r = 0.30, p = 0.029) and triple-negative breast cancer (TNBC) subtype (r = 0.37, p = 0.008). Here, ESR1 is linked to triple-negative breast carcinoma.